ISPOR Asia-Pacific Conference Program Committee Membership

The responsibility of the ISPOR Asia-Pacific Conference Program Committee is to develop a scientific program that meets the needs of the region and stimulates thought and debate amongst the delegation, and encourages participation and attendance to the Conference. The ISPOR Asia-Pacific Conference Program Committee consists of the following four subcommittees (Review Committees):

Membership on the ISPOR Asia-Pacific Conference Program Committee is open to all Asia Consortium members who are interested in assisting the development of the Conference program.

Asia-Pacific Conference Program Committee Activities

Join the Asia Consortium Asia-Pacific Conference Program Committee

ISPOR Asia-PacificConference is held every two years in September.
The ISPOR 8th Asia-Pacific Conference is to be held 8-11 September 2018, Tokyo, Japan.

ISPOR 8th Asia-Pacific Conference Program Committee

ISPOR 8th Asia-Pacific Conference Co-Chairs:
Takashi Fukuda, PhD
Takashi Fukuda, PhD
Director, Department of Health and Welfare Services, National Institute of Public Health, Saitama, Japan
Shinya Saito, MD, PhD
Shinya Saito, MD, PhD
Professor, Graduate School of Health Sciences, Okayama University, Tokyo, Japan
ISPOR 8th Asia-Pacific Conference Program Committee Co-Chairs:
Shunya Ikeda, MD, MS, DrMedSci
Shunya Ikeda, MD, MS, DrMedSci
Professor of Public Health and Pharmacoeconomics International University of Health and Welfare, Ohtawara, Japan
Kun Zhao, MD, PhD, MHSc
Kun Zhao, MD, PhD, MHSc
Professor & Director, Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center, National Health and Family Planning Commission (NHFPC), Beijing, China
Research Review Committee Co-Chairs:
Paul Scuffham, PhD
Paul Scuffham, PhD
Professor in Health Economics, Director of the Centre for Applied Health Economics (School of Medicine), and Deputy Director of the Menzies Health Institute, Queensland, Australia
Jing Wu, PHD
Jing Wu, PHD
Professor, Pharmaceutical Economics and Policy, Tianjin University, Tianjin, China
Eui-Kyung Lee, PhD, RPh
Eui-Kyung Lee, PhD, RPh
Professor of Pharmaceutical Policy and Outcomes Research, SungKyunKwan University (SKKU), Seoul, South Korea
Christopher Carswell, MSc
Christopher Carswell, MSc
Editor-in Chief, PharmacoEconomics, Springer Nature, Auckland, New Zealand
Issue Panel Review Committee Co-Chairs:
Vivian WY Lee, BSc, PharmD, BCPS
Vivian WY Lee, BSc, PharmD, BCPS
(Added Qualification in Cardiology), Associate Professor, School of Pharmacy, and Assistant Dean (Student Development), Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
Bhagwan Aggarwal, PhD, MBA, MSc, Mphil, BSc
Bhagwan Aggarwal, PhD, MBA, MSc, Mphil, BSc
Assistant Director & Head of Department, Environmental Carcinogen Unit / Molecular Biology, National Institute of Occupational Health (NIOH), Indian Council of Medical Research, Almedabad, India
Workshop Review Committee Co-Chairs:
Nathorn Chaiyakunapruk, PharmD, PhD
Nathorn Chaiyakunapruk, PharmD, PhD
Professor of Health Economics, School of Pharmacy, Monash University Malaysia, Selangor, Malaysia
Hui-Chu Lang, PhD
Hui-Chu Lang, PhD
Professor, Institute of Hospital and Health Care Administration, National Yang-Ming University, Taipei, Taiwan
Local Program Review Committee Members:
Hiroyuki Sakamaki, PhD
Hiroyuki Sakamaki, PhD
Professor, Department of Management, School of Management, Tokyo University of Science, Tokyo, Japan
Kojiro Shimozuma, MD, PhD
Kojiro Shimozuma, MD, PhD
Professor, Division of Health Services Research, Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan
Hiroyuki Okumura, PhD
Hiroyuki Okumura, PhD
Associate Director & Medical Science Staff, Medical Affairs, QA, RA and Pharmacovigilance, Astellas Pharma Inc., Tokyo, Japan
Chisato Hamashima, MD, PhD
Chisato Hamashima, MD, PhD
Research Scientist, Center for Public Health Science, National Cancer Center, Tokyo, Japan
Manabu Akazawa, PhD
Manabu Akazawa, PhD
Professor, Public Health and Epidemiology, Meiji Pharmaceutical University, Tokyo, Japan
Shinichi Noto, MS, PhD
Shinichi Noto, MS, PhD
Professor, Niigata Sogo Gakuen School Corporation, Niigata University of Health and Welfare, Niigata, Japan
Shuichi Yamaguchi
Shuichi Yamaguchi
HTA Group manager, External Affairs Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
Ataru Igarashi, PhD, MS
Ataru Igarashi, PhD, MS
Associate Professor, Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
Takeru Shiroiwa, PhD
Takeru Shiroiwa, PhD
Senior Researcher, Department of Health and Welfare Services, National Institute of Public Health, Saitama, Japan

Back to Asia Consortium main page